95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.85%
Negative revenue growth while NEM stands at 6.66%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-8.30%
Negative gross profit growth while NEM is at 7.79%. Joel Greenblatt would examine cost competitiveness or demand decline.
-1.75%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-1.75%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
4.90%
Positive net income growth while NEM is negative. John Neff might see a big relative performance advantage.
6.06%
Positive EPS growth while NEM is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
6.06%
Positive diluted EPS growth while NEM is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.09%
Slight or no buybacks while NEM is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
-0.31%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
25.60%
Dividend growth under 50% of NEM's 59.40%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
-8.83%
Negative OCF growth while NEM is at 5.64%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-8.64%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
50.22%
Positive 10Y revenue/share CAGR while NEM is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
27.97%
5Y revenue/share CAGR above 1.5x NEM's 17.93%. David Dodd would look for consistent product or market expansions fueling outperformance.
16.22%
3Y revenue/share CAGR similar to NEM's 16.12%. Walter Schloss would assume both companies experience comparable short-term cycles.
30.94%
10Y OCF/share CAGR 1.25-1.5x NEM's 22.40%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
39.76%
Below 50% of NEM's 292.63%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
24.07%
3Y OCF/share CAGR under 50% of NEM's 49.20%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
0.37%
Positive 10Y CAGR while NEM is negative. John Neff might see a substantial advantage in bottom-line trajectory.
183.27%
5Y net income/share CAGR at 50-75% of NEM's 305.49%. Martin Whitman might see a shortfall in operational efficiency or brand power.
212.45%
3Y net income/share CAGR similar to NEM's 203.91%. Walter Schloss would attribute it to shared growth factors or demand patterns.
98.34%
10Y equity/share CAGR above 1.5x NEM's 5.77%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
23.42%
5Y equity/share CAGR at 75-90% of NEM's 28.40%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
14.87%
Below 50% of NEM's 44.13%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
139.09%
Below 50% of NEM's 1347.81%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
39.29%
Below 50% of NEM's 431.67%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
-3.56%
Firm’s AR is declining while NEM shows 38.58%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
238799900.00%
Inventory growth well above NEM's 0.11%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-2.20%
Negative asset growth while NEM invests at 2.02%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
2.85%
BV/share growth above 1.5x NEM's 1.22%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-59.56%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-55.96%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.